biological source
rabbit
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
polyclonal
mol wt
calculated mol wt 50.81 kDa
observed mol wt ~75-80 kDa
purified by
affinity chromatography
species reactivity
human
species reactivity (predicted by homology)
bovine, rat, mouse
packaging
antibody small pack of 100
technique(s)
dot blot: suitable
flow cytometry: suitable
immunocytochemistry: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
immunoprecipitation (IP): suitable
western blot: suitable
isotype
IgG
epitope sequence
N-terminal
Protein ID accession no.
UniProt accession no.
storage temp.
2-8°C
target post-translational modification
phosphorylation (pSer56)
Quality Level
Gene Information
human ... RXRA(6256)
Application
Quality Control Testing
Evaluated by Western Blotting in lysate from HeLa cells in mitotic phase.
Western Blotting Analysis: A 1:1,000 dilution of this antibody detected RXR phosphorylated on serine 56 in lysate from HeLa cells in mitotic phase.
Tested Applications
Immunofluorescence Analysis: A representative lot detected RXR in Immunofluorescence application (Xie, G., et al. (2021). STAR Protocols. 2, :1-15).
Western Blotting Analysis: A representative lot detected RXR in Western Blotting application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Immunoprecipitation Analysis: A representative lot immunoprecipitated RXR in Immunoprecipitation application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Immunocytochemistry Analysis: A representative lot detected RXR in Immunocytochemistry application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Flow Cytometry Analysis: A representative lot detected RXR in Flow Cytometry application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Dot Blot: A representative lot detected RXR in Dot Blot application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Flow Cytometry Analysis: 1.0 µg of this antibody detected RXR in HeLa cells overnight serum-starved and treated with Nocodazole 100 ng/ml for 8 hours .
Immunohistochemistry Applications: A representative lot detected RXR in Immunohistochemistry application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Evaluated by Western Blotting in lysate from HeLa cells in mitotic phase.
Western Blotting Analysis: A 1:1,000 dilution of this antibody detected RXR phosphorylated on serine 56 in lysate from HeLa cells in mitotic phase.
Tested Applications
Immunofluorescence Analysis: A representative lot detected RXR in Immunofluorescence application (Xie, G., et al. (2021). STAR Protocols. 2, :1-15).
Western Blotting Analysis: A representative lot detected RXR in Western Blotting application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Immunoprecipitation Analysis: A representative lot immunoprecipitated RXR in Immunoprecipitation application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Immunocytochemistry Analysis: A representative lot detected RXR in Immunocytochemistry application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Flow Cytometry Analysis: A representative lot detected RXR in Flow Cytometry application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Dot Blot: A representative lot detected RXR in Dot Blot application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Flow Cytometry Analysis: 1.0 µg of this antibody detected RXR in HeLa cells overnight serum-starved and treated with Nocodazole 100 ng/ml for 8 hours .
Immunohistochemistry Applications: A representative lot detected RXR in Immunohistochemistry application (Xie, G., et al. (2020). Development Cell. 55, : 707-722).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Biochem/physiol Actions
This rabbit polyclonal antibody detects RXR phosphorylated on serine 56.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
General description
Retinoic acid receptor RXR-alpha (UniProt: P19793; also known as Nuclear receptor subfamily 2 group B member 1, Retinoid X receptor alpha, RXR ) is encoded by the RXRA (also known as NR2B1) gene (Gene ID: 6256) in human. Retinoid X receptor alpha (RXR ), a nuclear receptor of transcription factor, controls various physiological and pathological pathways including cellular growth, proliferation, differentiation, and apoptosis. RXR-alpha is composed of three domains: a modulating N-terminal domain (AF1 domain), a DNA-binding domain, and a C-terminal ligand-binding domain (AF2 domain). RXR-alpha protein is highly expressed in liver and its expression has also been reported in lung fibroblasts, monocytes, kidney, and brain. RXR is phosphorylated on serine and threonine residues mainly at its N-terminal A/B domain by cyclin-dependent kinase 1 (Cdk1) at the onset of mitosis, triggering its translocation to the centrosome, where phosphorylated-RXR (p-RXR ) interacts with polo-like kinase 1 (PLK1) through its N-terminal A/B domain by a unique mechanism. The interaction promotes PLK1 activation, centrosome maturation, and mitotic progression. Studies show that Cdk1 phosphorylation of Ser56 and Ser70 mediates the interaction between p-RXR and PLK1 during mitosis. Importantly, Ser56 and Ser70 and their surrounding amino acids are highly conserved across different species, suggesting their evolutionarily conserved role in regulating RXR activity. An RXR ligand XS060, which specifically inhibits p-RXR /PLK1 interaction but not RXR heterodimerization, promotes mitotic arrest and catastrophe in a tumor-specific manner. Levels of p-RXR are abnormally elevated in cancer cell lines, during carcinogenesis in animals, and in clinical tumor tissues. (Ref.: Xie, G., et al. (2020). Development Cell. 55(6); 707-722; Xie, G., et al. (2021). STAR Protocols. 2(3); 1-15; Zeng, Z., et al. (2015). Cancer Res. 75(10); 2049-2060.)
Immunogen
KLH-conjugated linear peptide corresponding to 12 amino acids from the surrounding phosphoserine 56 from the N-terminal region of human Retinoic acid receptor (RXR ).
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Physical form
Purified rabbit polyclonal antibody in PBS without azide.
Preparation Note
0.5 mg/mL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Recommended storage: +2°C to +8°C.
未找到合适的产品?
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持